![](/img/cover-not-exists.png)
69P The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy
Tsakiridis, T., Villani, L., Broadfield, L., Marcinko, K., Tsakiridis, E., Ellis, P., Muti, P., Steinberg, G.Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/S1556-0864(18)30345-9
Date:
April, 2018
File:
PDF, 78 KB
english, 2018